ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1419	National Cancer Institute	Html	en	Lung Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for lung cancer.	lung cancer screening 0.756773 initial screening test 0.3898 LDCT lung cancer 0.431859 sputum cytology 0.442562 U.K. Lung Cancer 0.42482 negative screening test 0.411746 lung cancer 0.9987 lung cancer mortality. 0.430481 current smokers 0.386204 intense screening regimen 0.386147 Early Lung Cancer 0.463536 chest imaging 0.420806 positive screening result 0.397336 lung abnormalities 0.397732 excess lung cancer 0.416122 Lung Screening Trial 0.503515 group 0.383474 intervention arm 0.382743 lung cancer problem 0.42431 positive screening test 0.414453 screening phase 0.386735 lung cancers 0.45033 major lung abnormality 0.402566 LDCT screening 0.417092 lung cancer cases 0.428353	randomized Danish Lung 0.39566 positive screening tests 0.398319 chest radiographic screening 0.412733 cancer screening program 0.414425 lung component 0.385589 Danish Lung Cancer 0.447818 Screening pilot trial 0.393797 Lung Cancer Action 0.443317 participants 0.389736 National Lung Screening 0.500437 Lung Cancer Detection 0.423833 CT screening program 0.391863 Randomized Lung Cancer 0.430455 small lung cancers 0.401362 screening exams 0.383361 lung cancer. 0.390552 lung cancer deaths 0.457228 PLCO Cancer Screening 0.408534 lung cancer death 0.470333 Mayo Lung Project 0.426524 screening test 0.418941 lung cancer mortality 0.632713 lung cancer incidence 0.423847 Cancer Screening Trial 0.513616	CLICK HERE
1542	National Cancer Institute	Html	en	Uterine Sarcoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of uterine sarcomas.	cancer treatment 0.326283 cancer spreads 0.27392 body 0.30595 PDQ cancer information 0.340432 clinical trial search 0.337812 uterus 0.36876 metastatic uterine sarcoma 0.28805 clinical trials 0.632813 cancer information summary 0.313263 clinical trial 0.463679 Transvaginal ultrasound exam 0.270971 patients 0.291529 Recurrent uterine sarcoma 0.312941 total abdominal hysterectomy 0.33979 treatment clinical trial 0.271689 NCI PDQ cancer 0.280198 Treatment Option Overview 0.316082 radiation therapy 0.397408 Treatment Editorial Board 0.278942 General information 0.276617 general cancer information 0.27165 treatment 0.476479 uterine sarcoma cells 0.294562 NCI-supported cancer 0.289424 cancer cells 0.449324	Cancer Information Service 0.272134 Uterine Sarcoma Treatment 0.298886 Option Overview section 0.306678 Uterine Cancer Home 0.286123 treatment clinical trials 0.296817 National Cancer Institute 0.35406 new treatment 0.296864 uterine sarcoma 0.941913 Uterine Sarcoma section 0.285791 diagnose uterine sarcoma 0.300059 PDQ summary 0.281429 uterine sarcoma spreads 0.28676 cancer clinical trials 0.348942 stage 0.302932 Endometrial Cancer Treatment 0.295433 high-energy sound waves 0.275392 fallopian tubes 0.310914 Tissue Sarcoma Treatment 0.291575 treatment options 0.275101 cancer information summaries 0.270428 comprehensive cancer information 0.27068 cancer 0.782046 information 0.353338 standard treatment 0.299992	CLICK HERE
1711	National Cancer Institute	Html	en	Breast Cancer Risk in American Women	A fact sheet that provides statistics about a woman’s risk of developing breast cancer and information about breast cancer risk factors.	current incidence rates 0.345094 Physical activity level 0.337892 woman’s risk 0.354657 certain genes 0.34342 breast cancer increases 0.425903 Certain breast changes 0.409974 Mammographic breast density 0.411613 Indian/Alaska Native women 0.346578 breast biopsies 0.390019 Breast Cancer Risk 0.442755 following risk factors 0.34953 close male blood 0.336852 slightly increased risk 0.378351 lifetime risk 0.357498 fatty tissue 0.342031 average American woman 0.385569 fatty tissue increases 0.340815 menopausal hormone therapy 0.39484 current incidence 0.346194 women 0.441907 United States 0.390167 atypical hyperplasia 0.338604 individual woman 0.344493 percent 0.39834	full-term pregnancy 0.359972 breast cancers 0.393892 specific ages 0.341748 dense breasts 0.348222 breast ducts 0.38994 breast tissue 0.419467 National Cancer Institute 0.363645 progestin menopausal hormone 0.339022 higher risk 0.34662 strongest risk factor 0.391772 breast cancer screening 0.434635 recent SEER Cancer 0.368992 breast cancer 0.950607 dense breast tissue 0.413692 annual SEER reports 0.34791 risk factor levels 0.353691 current incidence rate 0.341921 slight changes 0.340621 family history 0.345271 breast cancer incidence 0.450564 risk 0.535827 specific time periods 0.377721 10-year age intervals 0.347265 breast cancer statistics 0.446445	CLICK HERE
1787	National Cancer Institute	Html	es	Prurito (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del prurito (picazón de la piel) como complicación del cáncer y su tratamiento. Se consideran los abordajes de manejo y tratamiento del prurito.	funcionamiento renal 0.688505 cabo pruebas 0.675786 PDQ Prurito 0.877657 siguientes aspectos 0.726626 Diabetes mellitus 0.704562 Physician Data Query 0.887758 distintos tipos 0.680313 Tide Free 0.679893 cuidado personal 0.819492 líquidos suavizantes 0.680081 All Free Clear 0.98679	suficientes líquidos 0.704436 largo plazo 0.693554 medicamentos corticoesteroideos 0.689382 toallitas suavizantes 0.68595 determinada afección 0.743233 National Cancer Institute 0.676484 bastantes líquidos ayuda 0.75946 siguientes riesgos 0.661829 siguientes pruebas 0.722274 ropa all free 0.721127 Instituto Nacional 0.734946	CLICK HERE
1939	National Cancer Institute	Html	es	Adaptación al cáncer: ansiedad y sufrimiento (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las difíciles respuestas emocionales que se presentan en muchos de los pacientes con cáncer. Este sumario se enfoca en asuntos de la adaptación normal, alteración psicosocial y trastornos de adaptación.	La espiritualidad 0.829227 siguientes aspectos 0.951689 intensa ansiedad 0.886965 siguientes tipos 0.835996 largo plazo 0.911949 ¿Qué efectos 0.840354 siguientes períodos 0.85698 siguientes síntomas 0.824791 siguientes riesgos 0.776419 Visuals Online 0.784027 Physician Data 0.774429 siguientes problemas 0.817253	siguientes factores 0.894404 Mucha transpiración 0.807275 resultados correctos 0.846693 libre uso 0.789 siguientes situaciones 0.941031 Data Query 0.774207 siguientes características 0.904197 Cancer Institute 0.786402 página manejo 0.784108 suficiente dinero 0.80221 siguientes sumarios 0.945414 usa compulsiones 0.805006	CLICK HERE
2013	National Cancer Institute	Html	es	Aspectos generales de los exámenes de detección del cáncer (PDQ®)–Versión para pacientes	Información sobre la medición de la eficacia de los exámenes de detección del cáncer y la evaluación de la solidez de las pruebas obtenidas en estudios de investigación de detección del cáncer.	suficiente información 0.640426 riesgos.Algunos exámenes 0.948845 posibles factores 0.658466 End Results 0.782283 siguientes aspectos 0.657281 cabo ensayos 0.656668 ¿Los exámenes 0.83489 siguientes tipos 0.726625 efecto secundario adverso 0.681584 cuánto tiempo 0.658052 grupo pacientes 0.645515 información ayuda 0.635388 National Cancer Institute 0.643177	siguientes riesgos 0.629124 Instituto Nacional 0.984309 antecedentes familiares 0.663533 suficientes pruebas 0.65243 Physician Data Query 0.768953 Estados Unidos 0.927922 menor tiempo 0.639093 única razón 0.651582 posibles beneficios 0.675509 determinada enfermedad 0.640319 cuáles pruebas 0.82218 términos riesgo 0.746808 PDQ Aspectos 0.65214	CLICK HERE
3675	National Cancer Institute	Html	en	Data Submission Under the Genomic Data Sharing (GDS) Policy	Information for intramural, extramural, and non-NIH funded investigators looking to submit study data under the Genomic Data Sharing (GDS) Policy.	data instruments 0.389578 Different submission requirements 0.358856 Different data types 0.458311 data 0.914172 N/A Arrays 0.352863 Institutional Certification 0.390929 data use limitations 0.365334 phenotype data 0.455331 DNA sequence data 0.507348 clinical information 0.351464 N/A .BAM Arrays 0.717463 common data elements 0.45555 NCI intramural research 0.372571 RNAseq data 0.381683 submission process 0.341088 SNP array data 0.440533 Data reuse 0.406127 genomic data 0.788599 genomic program administrator 0.366093 controlled-access genomic data 0.507551 Raw data 0.388186 bisulfite sequencing data 0.488737 data sharing plan 0.431561 scientific review 0.378953	basis N/A .TXT 0.57172 GWAS data 0.384745 data standards 0.487591 published table 0.34424 human genomic data 0.471234 additional research questions 0.363874 data processing 0.449487 GDS policy-covered research 0.360223 human sample data 0.554048 GDS website 0.358009 DNA methylation data 0.435253 NIH data repositories 0.466908 minimizes potential errors 0.345345 data generation 0.367981 Developing Data Sharing 0.429887 exposure data 0.441991 well-documented data standards 0.480779 genomic data—such 0.394593 data submission 0.621641 data release 0.391289 NIH National Center 0.357378 genomic data submissions 0.597871 N/A .BAM NGS 0.52976	CLICK HERE
3768	National Cancer Institute	Html	en	NCI Research Specialist Award (R50)	Award enables scientists to pursue stable research careers within an existing cancer research program, but not serve as independent investigators. Letter of Intent due: January 2, 2017 Application due: February 2, 2017	Research Specialist Award 0.988915 core-based scientists 0.581471 grant applications 0.550206 stable research career 0.730099 NCI-funded cancer research 0.716667 PM local time 0.654064 Funding Opportunity Announcements 0.676968 context 0.428705 FOA 0.51866 laboratory-based scientists 0.56909 sufficient autonomy 0.601601 grants 0.427207 cancer research program 0.718023 development 0.427246	data scientists 0.569495 researchers 0.4266 biomedical research enterprise. 0.720253 Intent 0.437384 R50 0.455052 opportunities 0.427151 exceptional scientists 0.586489 applicant organization 0.552188 Principal Investigators 0.571254 core facility managers 0.705581 NCI Research Specialist 0.740871 career continuity 0.565048 FOAs 0.534084 independent investigators. 0.567464	CLICK HERE
15480	National Cancer Institute	Html	en	Grantees or Grant Applicants Submitting Data	In order to be compliant with the Genomic Data Sharing (GDS) Policy, extramural investigators should use the following to guide their steps through the grant life-cycle process.	annual Progress Report 0.62504 data 0.849889 Institutional Certification 0.882661 similar manner 0.478201 accession number 0.48592 section 0.333306 PO/PD 0.491096 Assignment 0.33161 approved DSP 0.538409 extramural investigators 0.782153 1. Plan Project 0.689974 Basic Study Information 0.674507 grant funding 0.568662 confirmation 0.333875 steps 0.331094 ARA 0.342301 submission portal 0.610861 plans 0.336284 grant application 0.941037 receipt 0.33802 GDS policy 0.525866 Upload Data 0.545134 dbGaP staff 0.485771 data certification process 0.735794 program officer/program director 0.674634	grants process 0.480049 grant life-cycle process 0.816123 Basic Information form 0.63633 dbGaP Study Release 0.648367 DSPs 0.34954 initiation 0.332734 pre-award process 0.509608 submission process 0.502601 required fields 0.479311 expectations 0.381962 place 0.332574 3. 0.332387 cleaning 0.332176 data submission formats 0.780089 study submission information 0.687432 Resource Sharing Plan 0.663305 QA/QC Data Submission 0.730259 Information form 0.651102 Submit Just-in-Time Materials 0.722172 Data Generation Completed 0.715899 GPA 0.642745 quality assurance check 0.641113 Write Grant Application 0.78666 data upload 0.531576	CLICK HERE
16861	National Cancer Institute	Html	es	Terapia Gerson (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de la terapia Gerson como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	múltiples detalles 0.301338 Centro Nacional 0.302469 New Hampshire Avenue 0.301732 Drug Administration 0.301078 NCI Best Case 0.303308 Max B 0.30156 datos bibliográficos pubmed 0.30187 cuerpo suficientes vitaminas 0.303678 Vitaminas A 0.301419 siguientes preguntas 0.30102 National Cancer Institute 0.302137 siguientes riesgos 0.301292 vitamina b12 0.301563 alto contenido 0.301449 Instituto Nacional 0.314894 Gerson Research Organization 0.308778 Salud Complementaria 0.303978 Visuals Online 0.301269	complementarias revisa 0.301833 PDQ Terapia Gerson 0.311186 Physician Data Query 0.307427 comidas vegetarianas 0.301548 coenzima q10 0.304748 Estados Unidos 0.316664 enzimas pancreáticas 0.305305 libre uso 0.301348 página manejo 0.301179 ¿El tratamiento 0.302348 suficiente potasio 0.301916 ¿Los beneficios 0.301092 juntos cam 0.301043 numerosos detalles 0.301552 Series Program 0.301073 terapia gerson 0.988974 medicina complementaria 0.349955	CLICK HERE